Showing results (271-280 of 310) with videos related to
Sort By:
Pageof 31
ACS Pharmacology & Translational Science|November 21, 2022
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical StudiesAnna Liu, Jenny Zhao, Milan Shah, et al.Applied Microbiology and Biotechnology|May 21, 2003
Diversification of exogenous genes in vivo in NeurosporaD E A Catcheside, J P Rasmussen, P J Yeadon, et al.Cancer Biology & Therapy|September 5, 2008
HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signalingCassandra A Godman, Rashmi Joshi, Brendan R Tierney, et al.BMC Psychology|November 28, 2021
Psychometric properties of the Brief Problem Monitor (BPM) in children with internalizing symptoms: examining baseline data from a national randomized controlled intervention studyMarit Løtveit Pedersen, Thomas Jozefiak, Anne Mari Sund, et al.Biotechniques|June 20, 2003
The LightTyper: high-throughput genotyping using fluorescent melting curve analysisC D Bennett, M N Campbell, C J Cook, et al.The Journal of Physiology|October 13, 2007
The cerebral metabolic ratio is not affected by oxygen availability during maximal exercise in humansS Volianitis, A Fabricius-Bjerre, A Overgaard, et al.Preventive Veterinary Medicine|July 11, 2024
Economic losses due to foot-and-mouth disease (FMD) in Ethiopian cattleP Rasmussen, A P Shaw, W T Jemberu, et al.Current Opinion in Toxicology|May 16, 2023
Nephrotoxicity of marketed antisense oligonucleotide drugsHangyu Wu, Aniket Wahane, Feryal Alhamadani, et al.Acta Neurochirurgica|January 1, 1980
Intracranial Saccular Aneurysms. Results of treatment in 851 patientsP Rasmussen, H Busch, J Haase, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|June 5, 2010
Effects of erythropoietin administration on cerebral metabolism and exercise capacity in menP Rasmussen, E M Foged, R Krogh-Madsen, et al.Pageof 31